Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit (HEPSY)

University Hospital Center (CHU)

Status: Completed

Conditions: Psychiatric Disorder; Liver Fibrosis; Advanced Chronic Liver Disease; Psychiatric Hospitalization

Treatments: Diagnostic Test: non invasive evaluation of liver fibrosis by transient elastography (Fibroscan ®)

Study type: Interventional

Funder types: Other

Identifiers

NCT05602870

RECHMPL22_0114

Details and patient eligibility

About

Scares data exists concerning the prevalence of chronic liver diseases in people with psychiatric disorders.

There are still many barriers to screening and linkage to care for patients having somatic illness.

Moreover follow-up of these patients may be difficult because of poor access to care, sometimes marginalization, and insufficient compliance with health programs.

The aim of this study is to asses acceptability of of advanced chronic liver disease screening by transient elstography (Fibroscan ®) in patients hospitalised in a psychiatric unit.

Full description

Scares data exists concerning the prevalence of chronic liver diseases in people with psychiatric disorders.

There are still many barriers to screening and linkage to care for patients having somatic illness.

Moreover follow-up of these patients may be difficult because of poor access to care, sometimes marginalization, and insufficient compliance with health programs.

Transient elastography is a useful tool validated for early diagnosis advanced chronic liver disease.It is non-invasive, fast, and gives immediate results.

The aim of this study is to assess acceptability of of advanced chronic liver disease screening by transient elstography (Fibroscan ®) in patients hospitalised in psychiatric unit.

Moreover, we will estimate de prevalence of advanced chronic liver diseases according to specific causes in psychiatry unit We hypothesize that the fact of offering psichiatric patents a non-invasive analysis of hepatic fibrosis will improve the detection of serious liver diseases and linkage to care.

Enrollment: 180 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

• adults ≥18 years
• having a psychiatric condition and hospitalized in a psychiatry unit of CHU Montpellier , France
• patients who lack capacity of consent if legal representative consents
• involuntary psychiatric hospitalization, if consent is given

Exclusion criteria

• lack of written consent
• Unable to understand nature and objective of the methodology
• Pregnant or breast feeding woman
• Not affiliated with a French social security

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

180 participants in 1 patient group

Psychiatric patient

Experimental group

Description:

All patients having psychiatric disorders and hospitalised in a Psychiatry Unit of CHU Montpellier will have an non invasive evaluation of liver fibrosis after giving their consent

Treatment:

Diagnostic Test: non invasive evaluation of liver fibrosis by transient elastography (Fibroscan ®)